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ABSTRACT: In this work, the biosensing and antibacterial capabilities of PVA-lysozyme microbubbles
have been explored. Gas-ﬁlled PVA-lysozyme microbubbles with and without gold nanoparticles in the
diameter range of 10 to 250 μm were produced using a single-step pressurized gyration process.
Fluorescence microscopy showed the integration of gold nanoparticles on the shell of the microbubbles.
Microbubbles prepared with gold nanoparticles showed greater optical extinction values than those
without gold nanoparticles, and these values increased with the concentration of the gold nanoparticles.
Both types of microbubbles showed antibacterial activity against Gram-negative Escherichia coli (E. coli),
with the bubbles containing the gold nanoparticles performing better than the former. The conjugation
of the microbubbles with alkaline phosphatase allowed the detection of pesticide paraoxon in aqueous
solution, and this demonstrates the biosensing capabilities of these microbubbles.
1. INTRODUCTION
Although microbubbles have been extensively explored for
clinical imaging and drug delivery purposes,1−6 little work is
reported on their antibacterial and biosensing properties.
Microbubbles could either be used to deliver antibiotics to
targeted bacterial strains7 or the microbubbles themselves could
be resistant to most of the common bacterial strains found in
clinical use.8 He et al.9 showed that ultrasound-targeted
microbubble destruction could enhance the vancomycin activity
against Staphylococcus epidermidis bioﬁlms. A microbubble
emulsion combined with sonic or ultrasonic agitation showed
increased resistance to Enterococcus faecalis bioﬁlms and
enhanced the antibioﬁlm eﬃcacy.10 Sonochemically formed,
antibiotics-loaded bovine serum albumin microspheres have
been used as antimicrobial agents against Staphylococcus aureus
(S. aureus) and E. coli in cotton fabrics.11 Sun et al.12 have
shown that monodisperse colloidal crystal beads are suitable for
multiplex bioassay and could be used in biosensing applications.
Lysozyme, which is an enzyme found in various biological
ﬂuids and tissues, has been used to form stable microbubbles
for protein and nucleic acid delivery.13 Lysozyme microbubbles
can also partially retain their antimicrobial activity despite their
denaturation.8 The stability of lysozyme microbubbles depends
on the denaturation and formation of thiol functional groups
and cross-linking.8,13 Indeed, the stability of microbubbles is
determined by the thickness and elasticity of shell material.14
Microbubble stability could also be achieved by particle
“jamming” at the interface14,15 or interfacial patterning which
arrests the shrinkage of bubbles.16 Alternatively, the stability
could be improved by the manipulation of shell composition.
The addition of polymers to the formulation will increase the
resistance to dissolution.17 Variation in polymer composition
alters the shell properties, thus aﬀecting microbubble shrinkage
and destruction.18
Pressurized gyration is an emerging technique that utilizes
centrifugal force and dynamic ﬂuid ﬂow to jet out microbubbles
consistently.19 In a typical pressurized gyration process, the
rotational speed and working pressure of the solution being
spun determine the morphology of the product; therefore,
careful selection of the operating conditions is vital to the
success of the process.19,20 A map of rotational speed and
working pressure has identiﬁed the microbubble formation
region for PVA-lysozyme protein solutions.19 It has been shown
that below a critical minimum pressure and a critical minimum
rotational speed no microbubbles are formed due to either
insuﬃcient ﬂuid ﬂow or centrifugal speed. This work also
uncovered that the stable optically tunable microbubbles can be
prepared by pressurized gyration. Here we explore the
biosensing and the antibacterial activity of the PVA-lysozyme
microbubbles formed by pressurized gyration.
2. EXPERIMENTAL DETAILS
2.1. Materials. Poly(vinyl alcohol) (PVA) (Mw = 146−186 kDa,
87−89% hydrolyzed) and lysozyme from chicken egg white (Mw =
14.3 kDa, ∼70 000 U/mg) were obtained from Sigma-Aldrich, U.K.
Both were used as received without any modiﬁcation. Gold
nanoparticles (average diameter ∼10 nm) in phosphate-buﬀered
saline (PBS) solution were obtained from Sigma-Aldrich, U.K. Alkaline
phosphatase, p-nitrophenyl phosphate (p-NPP), and paraoxon were
purchased from Sigma-Aldrich, U.K.
2.2. Solution Preparation and Characterization. PVA powder
was dissolved in distilled water and mixed using a magnetic stirrer for 2
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h at 90 °C to prepare the 10% w/v PVA solution. Once the 10% w/v
PVA solution was cooled to ∼4 °C, lysozyme powder was dissolved in
the PVA solution to produce a 4% w/v solution. Lysozyme was
completely dissolved by gentle mixing with a magnetic stirrer to make
a homogeneous solution (8 wt % PVA and 4 wt % lysozyme).
Although this solution was very viscous (∼720 mPa s) it remained a
liquid at ∼4 °C. Once samples were prepared they were stored at 4 °C
and were used within 24 h. The gold nanoparticle solution and PVA-
lysozyme solution with v/v ratios of 1:10, 1:5, and 2:5 were used to
prepare the gold-nanoparticle-containing microbubbles. The solutions
were mechanically stirred at 80 °C for 1 h prior to pressurized
gyration.
The surface tension and the viscosity of the PVA-lysozyme solutions
and PVA-lysozyme solutions containing gold nanoparticles were
measured. A Kruss K9 tensiometer was used to measure the static
surface tension of the solutions (Wilhelmy plate method). The
Figure 1. PVA-lysozyme microbubble size distribution and corresponding optical micrograph obtained at rotational speeds (rpm) of (a) 10 000, (b)
24 000, and (c) 36 000. In all instances the working pressure was 0.2 × 105 Pa.
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viscosity of the polymer solutions was measured using a BrookField
viscometer. All equipment was calibrated before use, and all
measurements were performed at ambient temperature (∼20 °C).
2.3. Bubble Preparation. The experimental setup used at ambient
temperature in this study has been described in detail in our previous
work.19 Brieﬂy, it consists of a rotary aluminum cylindrical vessel (∼60
mm in diameter and ∼35 mm in height) containing oriﬁces (20) on its
face. The size of one oriﬁce is 0.5 mm. One end of the vessel was
connected to a motor which can generate speeds of up to 36 000 rpm,
while the other end was connected to a nitrogen gas stream, the
pressure of which can be varied up to 3 × 105 Pa. The dynamics of the
process has been studied in detail,19 and the microbubbles evolve from
the breakup of a jet which results from the rotating motion. To
facilitate the collection of microbubbles, a stationary collector made of
aluminum foil was placed around the spinning vessel. There was no
deliberate attempt to control the bubble size and size distribution
where the applications targeted (bacteria scavenging and biosensing)
can tolerate coarser/polydisperse bubbles, unlike in ultrasound and
drug delivery applications.
2.4. Structural Characterization. Microbubble samples depos-
ited in the aluminum foil were collected using glass microscope slides.
These were sealed in a Petri dish and maintained at ambient
temperature. The microbubbles and their physical stability were
observed using a Nikon Eclipse ME600 optical microscope over a
period of 3 h. More than 100 microbubbles were studied using
IMAGE J software (version 1.46r). The microbubbles were also
characterized using the ﬂuorescence microscope (EVOS FL) to verify
the layer of gold nanoparticles on the shell of the microbubbles.
The relics of microbubbles formed were studied using ﬁeld emission
scanning electron microscopy (FE-SEM, model JSM 6301 F). Before
imaging, samples were coated with carbon using an Edwards S1 50B
sputter coater for 75 s. Ultraviolet−visible spectroscopy studies (UV−
vis spectroscopy) were performed on the microbubble samples
collected on glass slides using a PerkinElmer Lambda 35 spectrometer
with a 4 nm spectral resolution at 25 °C in the 200−700 nm
wavelength range.
2.5. Antibacterial Activity. The antibacterial activity of PVA-
lysozyme and the gold nanoparticles containing PVA-lysozyme
microbubbles was determined by staining and bacterial counting
using E. coli as a model organism. Initially, the bacterial suspensions
were prepared using a sterile laminar ﬂow hood environment at
ambient temperature. E. coli (6 μL) containing approximately 1 × 109
CFU/mL was diluted with 12 mL of Lauri-Bertani (LB) broth to
create an E. coli suspension. At this point each of the diﬀerent
microbubble samples was divided into an equal volume to be added to
each well in a 12-well plate, followed by 0.5 mL of the E. coli
suspension. This allowed three repeats for each of the microbubble
samples to be tested, in addition to three repeats of a control. The 12-
well plate was then left to incubate in a shaking incubator for 3 h to
allow thorough mixing of the microbubbles with the bacterial
suspension. Thereafter, 1:10, 1:100, and 1:1000 dilutions of the
incubated suspension containing E. coli and the samples were made.
Tryptic soy agar Petri dishes were then used to inoculate the samples
with varying concentrations. Each Petri dish was divided into quarters,
20 μL of diﬀerent concentrations of a particular sample was dropped
into the segment, and L-shaped plastic spreaders were used to
distribute each drop into the shape of a quadrant. These Petri dishes
were incubated at 38 °C for 24 h. Then, the Petri dishes were
individually placed on the colony counter, and the bacteria were
manually counted in order to calculate the antibacterial rate. The test
is known as a 3 h test since this period of time represents the length of
incubation time of E. coli and the samples, prior to the incubation of
Figure 2. (a) Stability analysis of the microbubbles. (b)−(e) Optical micrographs of the PVA-lysozyme microbubbles at diﬀerent times (hour): (b)
0, (c) 1, (d) 2, and (e) 3. (f) Field emission scanning electron microscope images of PVA-lysozyme microbubble relics.
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the Petri dishes. The antibacterial rate was calculated where possible
using the following equation
= × −A B
A
antibacterial rate (%) 100
(1)
where A is the average number of bacteria on the control (colony-
forming units (CFU)/sample) sample and B is the average number of
bacteria on the samples being tested (CFU/sample).
Fluorescence microscopy was also used to image the microbubbles
after attachment to the bacterial cells. For this purpose the cultured
microbubbles were stained with methylene blue (MB) in phosphate-
buﬀered saline (PBS, pH ∼7.2) and kept at 5 °C for 2 h. Then they
were washed with PBS for 10 min and dried before imaging.
2.6. Biosensing. Biosensing characteristics of the PVA-lysozyme
microbubbles were evaluated by the conjugation of alkaline
phosphatase (AP) to the microbubbles. This was carried out by the
reaction of 1 mg/mL microbubbles with 0.5 mg/mL malemide-
functionalized AP (m-AP) in 50 mM PBS at pH 7.2 for 15 min at
ambient temperature under gentle stirring. The reaction mixture was
ﬁltered out, and the remaining microbubbles were collected for
biosensing characterization. The biosensing characteristics of m-AP-
functionalized PVA-lysozyme microbubbles were evaluated by the
detection of paraoxon which was used as a model compound in
aqueous solution with and without p-NPP using a UV/vis
spectrometer.
3. RESULTS AND DISCUSSION
The optical micrographs and the corresponding size distribu-
tion of the formed microbubbles under diﬀerent rotation
speeds and a constant working pressure of 0.2 × 105 Pa are
shown in Figure 1. The working pressure has been chosen from
the parametric plot constructed for the pressurized gyration of
PVA-lysozyme solution as a function of rotational speed and
working pressure.19 The working pressure falls within the
microbubble-forming region and is good enough to prepare
bubbles at all rotation speeds. Microbubbles in the range of
10−250 μm were produced. Increasing rotational speed
reduced the mean microbubble size. The polydispersity indices
of the microbubble size distribution generated are 33, 40, and
57% for rotational speeds of 10 000, 24 000, and 36 000 rpm,
respectively. Thus, increasing the rotational speed increased the
polydispersity index and shows that the microbubble size and
distribution could be controlled.
The stability analysis of the microbubbles is shown in Figure
2a. The mean bubble diameter decreased with holding time.
The bubble diameter was nearly halved when the holding time
increased from 0 to 3 h. The gold-nanoparticle-containing
microbubbles were more stable than the PVA-lysozyme
Figure 3. (a) Optical extinction phenomenon of microbubbles with and without gold nanoparticles (a.u. denotes arbitrary units). (b) Number of
nanoparticles per microbubble as a function of gold nanoparticle concentration in solution. (c) Fluorescence microscopy image of the microbubbles
containing gold nanoparticles. (d) Fluorescence microscopy image of the microbubbles without gold nanoparticles. (Insets in c and d show
corresponding optical micrographs.)
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microbubbles and this became more apparent as the gold
nanoparticle concentration was increased. The gold nano-
particle concentration also inﬂuenced the stability of the
microbubbles where more stable microbubbles were obtained
with a higher concentration of the gold nanoparticles. Figure
2b−e shows the PVA-lysozyme microbubbles present at
diﬀerent times. Bubble relics were also studied with SEM
(Figure 2f). The microbubbles are spherical and have a
relatively smooth surface. The microbubbles constitute a thick
shell, and there is no apparent change in the bubble surface due
to gyration. It was initially thought that the shearing action of
the gyration vessel might lead to deformed surfaces; however,
these results show that there is no correlation between the
bubble surface and the gyration process (Figure 2b,c). A closer
examination of the microbubble surface after 2 and 3 h (Figure
2d,e) showed changes in shape and morphology. This is
associated with the change in Laplace pressure over this period
of time and the chemical modiﬁcation of the shell of the
microbubbles.19
The data in Figure 2 shows that the PVA-lysozyme
microbubble diameter stabilized at ∼37 μm about 2 h after
preparation. The stability of these microbubbles can be
attributed to thermal denaturation where the PVA-lysozyme
solution is heated to 80 °C prior to their preparation. The egg
white lysozyme consists of 129 amino acids in the primary
sequence and 4 intrachain disulﬁde bridges buried inside the
hydrophobic core of the protein,8 and the heating can break
intrachain disulﬁde bonds to form free thiol groups. This could
be attained by either chemical or thermal denaturation. In both
cases the active thiol groups that are formed improve the
formation as well as cross-linking properties that stabilize the
microbubbles.8 In addition, the chemical features of the PVA
polymer chain in aqueous solutions form clusters of entangled
chains stabilized by both hydrophobic interactions and
intermolecular and intramolecular hydrogen bonds. The
segregation of PVA at the shell of the microbubbles forms a
backbone for the stabilization process (physical adsorption).21
The elasticity of the shell material is attributed to the stability
of the microbubbles. Proteins can play a vital role in forming an
elastic interface and a viscous elastic shell. This can be
accomplished by the adsorption of proteins at the interface.
The viscous nature of the shell arises from the rearrangements
of intramolecules or intermolecules. When there is excess
molecular interaction the interface becomes more elastic.22
Moreover, the elasticity of the microbubble interface increases
with the shell thickness. The greater the shell thickness, the
higher the elasticity of microbubble shell. This improves the
stability of the microbubbles by stopping the shrinkage due to
disproportionation. In addition, a considerable amount of
stability in the microbubbles can be achieved over a period of
time from the intrabubble interaction. Moreover, microbubble
disproportionation can be averted by interfacial viscosity which
aids the stabilization process. Earlier work reports that there is
no obvious eﬀect of interfacial viscosity on the microbubble
dissolution process when low interfacial viscosity prevails,23 but
the bubbles’ shrinkage could be delayed. However, a greater
stability of the microbubbles could be achieved by the presence
of higher interfacial viscosity, which tremendously reduces
bubble dissolution.23
The stability of microbubbles can be greatly improved by the
adsorption of solid nanoparticles, i.e., gold in this work, on the
bubble surfaces by a phenomenon called jamming.24 This is
identical to a well-known phenomenon called Pickering
stabilization in liquid−liquid emulsions.25 This behavior is
also observed in foams.26 The nanoparticles which possess
signiﬁcant adsorption energy can form a rigid shell at the
interface of the microbubbles. These surface-active particles can
stop microbubble shrinkage due to disproportionation. There-
fore, by having a delicate balance between two tendencies, i.e.,
adsorption of the hydrophobic particles at the shell and the
dispersion of particles in the liquid medium in which they are
contained, improved stabilization can be obtained. In addition,
there is some rearrangement of surface-active particles
happening during disproportionation, and further adsorption
of particles to the microbubble interface can take place, forming
a more close-packed particle layer necessary for stability.26
The optical extinction spectra of the PVA-lysozyme and the
gold nanoparticles containing PVA lysozyme microbubbles are
shown in Figure 3a. They represent the optical scattering of the
gas core and the absorption of the gold nanoparticles. The
absorption by the gold nanoparticles is observed at a plasmon
resonance frequency of ∼530 nm. The PVA-lysozyme micro-
bubbles do not show any apparent peak, but in contrast, the
gold-nanoparticle-containing PVA-lysozyme microbubbles
showed a sharp peak. It is also seen that the sharpness and
the extinction values changed with the concentration of the
gold nanoparticles used. Figure 3b shows how the nanoparticles
per microbubble can be varied with the mole fraction of the
gold nanoparticles added to PVA-lysozyme. At 0.1 mol % the
number of nanoparticles per microbubble is 1.25 × 1011. As
expected, the number of nanoparticles per microbubble
increased with the concentration of the gold nanoparticles.
Moreover, the higher surface area of the gold nanoparticles
facilitated the binding of particles to the surface of micro-
bubbles. The binding of gold nanoparticles to the surface of a
microbubble was veriﬁed with ﬂuorescence microscopy (Figure
3c). The brighter shell of the microbubbles (cf. Figure 3d)
indicates the presence of gold nanoparticles.
The attachment of gold nanoparticles to the bubble surface is
irreversible and stabilizes the surface. The formation of gold
nanoparticles containing microbubbles depends on a delicate
balance between the tendency of the hydrophobic particles to
adsorb at microbubble surfaces and their tendency to aggregate
rather than disperse in water. Moreover, microbubbles need to
shrink appreciably to achieve stable disproportionation, and this
suggests that during shrinkage there may be some rearrange-
ment of the particles adsorbed on the microbubble surface and/
or further adsorption of particles to the microbubbles, resulting
in a more close-packed particle layer necessary for long-term
stability.26 In addition, the combination of rapid dissolution and
slow particle transport and adsorption, coupled with bubbles of
diﬀerent sizes competing to capture the gold nanoparticles,
gives rise to a rich variety of behaviors. For instance, the bubble
size distribution varies with the number of nanoparticles
available to bind in the shell layer before full stabilization is
achieved. The magnitude of variation in the spread of the size
distribution is also sensitive to the number of nanoparticles
available.27 Apart from being a very good stabilization agent,
gold nanoparticles are well known for their biosensing
applications.28 It has been shown that gold nanoparticles
binding to DNA have increased ampliﬁcation and have been
used to detect very low concentrations of thrombin.28 Thus,
biosensing is also investigated in this work.
The antibacterial properties of the microbubbles were
evaluated using Gram-negative E. coli microorganisms. The
interaction of the bacterial cells with the microbubble
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suspension was captured in real time and is shown in the
Supporting Information. Three samples from each PVA-
lysozyme, gold-nanoparticle-containing PVA-lysozyme micro-
bubbles, and control groups were investigated. Figure 4 shows
the plots of the antibacterial rate of the E. coli microorganisms
after 3 h for PVA-lysozyme microbubbles and gold-nano-
particle-containing PVA-lysozyme microbubbles. As the contact
time increased, the percentage (%) of bacterial colonies
decreased. This is clearly exempliﬁed in the Supporting
Information video which shows the interaction of the bubbles
and bacterial colonies. The average antibacterial rates after 3 h
were ∼60% and ∼75% for PVA-lysozyme microbubbles and
gold-nanoparticle-containing PVA-lysozyme microbubbles, re-
spectively. The percentage reduction was higher for gold-
nanoparticle-containing PVA-lysozyme microbubbles than for
the PVA-lysozyme microbubbles. For gold-nanoparticle-con-
taining PVA-lysozyme microbubbles, samples 2 and 3 have the
same antibacterial rate whereas sample 1 has a diﬀerent rate.
This might be due to the variation of the accumulation time
taken for bacterial cells to reach the microbubble surfaces. On
the other hand PVA-lysozyme microbubbles have identical
antibacterial rates for all three samples. Figure 5 shows the
optical micrographs of the control group and the microbubbles
containing a bacterial suspension. The typical morphology of E.
coli shows rodlike shape and is consistent with earlier reports.29
It is clearly seen that bacterial cell clusters were apparent in
microbubbles containing a bacterial suspension (Figure 5b,c)
compared to the control group (Figure 5a).
The antibacterial activity of PVA-lysozyme microbubbles is
signiﬁcantly higher than that of PVA and lysozyme solutions
acting individually. For example, from Figure 4a, after 3 h,
combining the PVA and lysozyme solutions gives an
antibacterial rate of 37.2%, and the correponding experimental
value is 36.7%. These values are signiﬁcantly lower than that of
the PVA-lysozyme microbubbles which have an average
antibacterial rate of 59% after 3 h. The average antibacterial
activity of the gold nanoparticle containing PVA-lysozyme
microbubbles is 73% after 3 h (Figure 4b) and therefore clearly
demonstrates the eﬀect the gold nanoparticles had on the
antibacterial activity. The bare gold nanoparticles give an
antibacterial rate of 46.6% at 3 h. Therefore, the antibacterial
activity of gold nanoparticles is higher than the PVA, lysozyme,
and PVA-lysozyme mixture, and this is most probably due to
the fact that gold nanoparticles have a higher surface area which
promotes bacterial cell attachement and cell lysis. Individual
addition of PVA, lysozyme, and gold nanoparticles gives a total
antibacterial rate of 83.8% at 3 h. However, the experimental
value of this mixture at the same time is 48.4%, which is
signiﬁcantly lower and indeed even lower than for the gold-
nanoparticle-containing PVA-lysozyme microbubbles. But the
value is considerably higher than for the PVA-lysozme mixture.
Again, this shows the eﬀect that gold nanoparticles had on the
antibacterial activity. The reason for the lower antibacterial
activity of the PVA-lysoyme-gold mixture compared to that of
individual addition is that, in the mixture, the gold nanoparticles
may be buried or coated with PVA-lysozyme solution that will
hinder the exposure of the gold nanoparticle surface to bacterial
cells, thus lowering the antibacterial activity. In addition, for
eﬀective antibacterial activity the gold nanoparticles have to be
homogeneously distributed in the solution, and this is more
eﬀectively done in the microbubble suspension (i.e., on the
surface, bubbles are decorated with gold nanoparticles) than in
the PVA-lysozyme mixture.
It has been shown that denatured lysozyme is a potent
antibactericidal agent against both Gram-negative and Gram-
positive microorganisms.30 Lysozyme is an antimicrobial
enzyme characterized by a single polypeptide chain and by
enzymatic activity against β-1,4 glycosidic bonds between N-
acetylmuramic acid and N-acetylglucosamine.31 Regardless of
its enzyme activity, the lysozyme has been shown to possess
antimicrobial activity.8,30 In the denatured lysozyme, β-sheets
are major structures holding the monomers in dimeric form.
On the surface of the dimer, increased hydrophobicity and half-
cystines contribute to the antibacterial action by increasing the
permeability of the membrane.30 Moreover, the reduction of
disulﬁde bonds (S−S) could expose many hydrophobic groups
and tryptophan (Trp) residues, enabling the microbubbles to
interact with the bacterial membrane.32 In addition, by
triggering autolysin activity, lysozyme may kill the bacteria.
Autolysins are a subset of peptidoglycan-synthesizing enzymes,
the activation of which causes bacteria to form the faulty
peptidoglycan and lyse.33 The bacterial cell wall tends to attract
positively charged lysozyme microbubbles because of the total
charge of the cell wall being negative, and thus the cell wall
under high stress can cause immediate cell lysis.
Figure 4. Antibacterial activity of microbubbles. (a) PVA-lysozyme
and (b) gold-nanoparticle-containing PVA-lysozyme (2:5 v/v). The
data for PVA is obtained from ref 43.
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It is also worth mentioning here that comparing the
antibacterial activity of lysozyme solution with the lysozyme
microbubbles is not meaningful since most of the protein in the
microbubble is buried within the shell of the microbubble.8 It is
interesting to see that gold-nanoparticle-containing PVA-
lysozyme microbubbles have higher antibacterial activity than
the PVA-lysozyme microbubbles. The gold nanoparticle
interacts with the cell membrane of E. coli and forms a distinct
aggregation pattern and lysis of bacterial cells.34 Also, the
blebbing caused by cationic gold nanoparticles induces bacterial
membrane damage.35 The antibacterial activity of the gold
nanoparticles depends on the speciﬁc surface area. The gold
nanoparticles possess a higher surface area and can attach more
cell membranes to its surface and disturb its power function
such as permeability and respiration.36 Moreover, the electro-
static interaction between the gold nanoparticle and the cell
surface induces stress in the membranes, which leads to cell
damage.37
The biosensing characteristics of the PVA-lysozyme micro-
bubbles were evaluated by the conjugation of m-AP to the
bubble surface and thereafter detection of the paraoxon analyte
at very low concentrations. Paraoxon is an organophosphorous
(OP) pesticide widely used as an insecticide which adversely
aﬀects the human brain and tissues. These compounds are
structurally very similar to nerve gases and are well known for
their inhibition of acetylcholinesterase, which is responsible for
transmitting nerve impulses across synaptic junctions.38 The
OP compounds are poisonous when inhaled, ingested, or
absorbed through the skin. Therefore, the development of
sensors capable of detecting harmful concentrations of these
compounds would be beneﬁcial to humans and livestock
populations.39 The AP catalyzes the hydrolysis of phenyl
phosphates to phenols.
The calibration curve for the biosensing process is shown in
Figure 6a. Initially absorbance is obtained at various
concentrations of paraoxon with and without p-NPP. The
degree of inhibition of paraoxon with respect to the enzymatic
activity of AP was measured as the relative decrease in
absorbance observed after mixing microbubbles and paraoxon.
This has been shown schematically in Figure 6b. The diﬀerence
in absorbance is plotted against the analyte paraoxon
concentration. The absorbance varies linearly with the
paraoxon concentration. A 20% competitive inhibition of
enzymatic activity was observed for m-AP functionalized with
PVA-lysozyme microbubbles with 0.5 ppm paraoxon. A wide
variety of techniques such as gas chromatography, high-
performance liquid chromatography, and electrochemical
methods have been devised to detect the presence of OP
compounds, and these techniques are time-consuming,
expensive, and complex. To overcome these problems,
enzymatic bioassays have been designed for enhanced
detection, high eﬃciency, and sensitivity to OP compounds.40
Figure 5. Optical micrographs of (a) the control group (E. coli suspension), (b) the interaction of microbubbles with an E. coli suspension, and (c)
stable microbubbles leading to cell lysis on the surface of the microbubbles.
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The enzymatic bioassay based on microbubbles developed and
presented here is equivalent to the higher detection limit of
paraxon obtained by colorimetric detection.41 More impor-
tantly, it satisﬁes the requirement of the current pesticide
residue standard of the European Union for the detection of
paraoxon.41 In addition, these microbubble-based bioassays
show better detection capability than the semiconductor CdSe-
based biosensors42 and are cheaper and easier to handle.
Therefore, designing and engineering such a functional system
could be used over a broad application area including diagnostic
tools and environmental bioassays. In addition, optical,
magnetic, and potentially plasmonic functionalities may be
embedded within the microbubbles to explore a wide range of
healthcare applications.
4. CONCLUSIONS
Bubbles up to 250 μm in diameter were produced by
pressurized gyration using a series of protein solutions (PVA-
lysozyme), and the bubble diameter was reduced by increasing
the rotational speed. A unimodal size distribution was obtained
for all of the rotational speeds at a constant working pressure
which was selected appropriately to form microbubbles from
the PVA-lysozyme system. The mean microbubble size was
reduced from ∼100 to ∼50 μm when increasing the rotational
speed from 10 000 to 36 000 rpm. The optical extinction values
of the gold-nanoparticle-containing microbubbles were higher
than for the bare protein microbubbles. These values increased
with the increase in concentration of the gold nanoparticles and
reached 450, a 4-fold increase, at a gold nanoparticle
concentration of 40%. The antibacterial activity of the protein
microbubbles was tested with the Gram-negative E. coli
microorganism, and increased activity was found for gold-
nanoparticle-containing microbubbles compared to that of the
bare protein microbubbles. The average antibacterial activity for
gold-nanoparticle-containing microbubbles was found to be
73% whereas bare protein microbubbles showed 59% activity.
The mechanisms of antibacterial activity include the interaction
of positively charged lysozyme microbubbles with the
negatively charged cell wall, thus putting the cell wall under
high stress which can cause immediate cell lysis. The biosensing
capabilities of the microbubbles prepared were also investigated
using paraoxon. The detection of paraoxon levels of as low as
0.5 ppm was possible with alkaline phosphatase-conjugated
microbubbles, and this demonstrates a better detection
capability than with other bioassays.
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